Diagnos Laboratorium Utama Tbk. vs Yupi Indo Jelly Gum Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp218 (market cap 308B, 73.4K 24h volume), while Yupi Indo Jelly Gum Tbk. trades at Rp1,320 (market cap 11.36T, 55.7K 24h volume). The key difference: Yupi Indo Jelly Gum Tbk. is far larger — about 36.9× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (73.4K versus 55.7K). Which is the better fit depends on your goals.
| DGNS | YUPI | |
|---|---|---|
Market Cap | 308B | 11.36T |
Volume | 73.4K | 55.7K |
Lot | 734 | 557 |
Turnover | 16.33M | 74.18M |
Average Price | 222.52 | 1,331.78 |
Value | 16.33M | 74.18M |
Indicative Equilibrium Price | 230 | 1,330 |
Indicative Equilibrium Volume | 110 | 2.9K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT. Yupi Indo Jelly Gum Tbk. (the Company) was established in Republic Indonesia dated July 6, 1995 based on Notarial Deed No. 38 of Sutjipto, S.H., dated July 6, 1995. The Company parent entity and ultimate parent entity are PT. Sweets Indonesia and PT. Cipta Astana Gemilang, respectively.
Read more on YUPI →